AG真人官方

STOCK TITAN

Blazing Star Merger Sub, Inc. announces extension of the expiration time and settlement date for the previously announced Tender Offer and Consent Solicitation for any and all Walgreens Boots Alliance, Inc.'s 3.600% senior notes due 2025, 2.125% senior notes due 2026, 3.450% notes due 2026, 8.125% notes due 2029, 3.200% Notes due 2030, 4.500% senior notes due 2034, 4.800% senior notes due 2044, 4.650% notes due 2046 and 4.100% Notes due 2050, and any and all of Walgreen Co.'s 4.400% notes due 2042

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)

Blazing Star Merger Sub has extended the expiration time and settlement date for the previously announced tender offer and consent solicitation for Walgreens Boots Alliance (NASDAQ: WBA) notes. The expiration time has been extended to 5:00 p.m., New York City time, on August 21, 2025, with settlement now scheduled for August 26, 2025.

The tender offer covers multiple series of senior notes with various interest rates and maturities ranging from 2025 to 2050. Significant portions of each note series have already been tendered, with participation rates ranging from 84.7% to 98.1% across different note series. The tender offer is conditional upon the closing of WBA's acquisition by Blazing Star Parent, LLC, where WBA will become a wholly-owned subsidiary.

Blazing Star Merger Sub ha prorogato l'orario di scadenza e la data di regolamento dell'offerta in contanti e della richiesta di consenso precedentemente annunciate per le obbligazioni di Walgreens Boots Alliance (NASDAQ: WBA). Il termine 猫 stato esteso fino alle 17:00, ora di New York, del 21 agosto 2025, mentre il regolamento 猫 ora previsto per il 26 agosto 2025.

L'offerta riguarda pi霉 serie di obbligazioni senior con tassi d'interesse e scadenze differenti, comprese tra il 2025 e il 2050. Una quota significativa di ciascuna serie 猫 gi脿 stata presentata all'offerta, con tassi di partecipazione che variano dal 84,7% al 98,1% a seconda della serie. L'offerta 猫 subordinata al completamento dell'acquisizione di WBA da parte di Blazing Star Parent, LLC, dopo la quale WBA diventer脿 una controllata interamente detenuta.

Blazing Star Merger Sub ha ampliado la hora de vencimiento y la fecha de liquidaci贸n de la oferta p煤blica de adquisici贸n y la solicitud de consentimiento anunciadas anteriormente para los bonos de Walgreens Boots Alliance (NASDAQ: WBA). El plazo se ha ampliado hasta las 5:00 p.m., hora de Nueva York, del 21 de agosto de 2025, y la liquidaci贸n est谩 ahora programada para el 26 de agosto de 2025.

La oferta cubre varias series de bonos senior con distintos tipos de inter茅s y vencimientos entre 2025 y 2050. Ya se han presentado cantidades significativas de cada serie, con tasas de participaci贸n que oscilan entre el 84,7% y el 98,1% seg煤n la serie. La oferta est谩 condicionada al cierre de la adquisici贸n de WBA por parte de Blazing Star Parent, LLC, tras la cual WBA pasar谩 a ser una filial de propiedad total.

Blazing Star Merger Sub電� 鞚挫爠鞐� 氚滍憸霅� Walgreens Boots Alliance (NASDAQ: WBA) 毂勱秾鞐� 雽頃� 鞚胳垬 鞝滌晥 氚� 霃欖潣 鞖旍箔鞚� 毵岆 鞁滉皠瓿� 瓴办牅鞚检潉 鞐办灔頄堨姷雼堧嫟. 毵岆 鞁滉皠鞚 2025雲� 8鞗� 21鞚� 雺挫殨鞁� 旮办 鞓ろ泟 5鞁�搿� 鞐办灔霅橃棃瓿�, 瓴办牅電� 鞚挫牅 2025雲� 8鞗� 26鞚�搿� 鞓堨爼霅橃柎 鞛堨姷雼堧嫟.

鞚措矆 鞚胳垬 鞝滌晥鞚 2025雲勲秬韯� 2050雲勱箤歆 雼れ枒頃� 鞚挫湪瓿� 毵岅赴毳� 臧歆� 鞐煬 鞁滊Μ歃堨潣 鞁滊媹鞏� 雲疙姼毳� 雽靸侅溂搿� 頃╇媹雼�. 臧� 鞁滊Μ歃堨潣 靸侂嫻 攵攵勳澊 鞚措 鞝滌稖霅橃棃鞙茧┌, 彀胳棳 牍勳湪鞚 鞁滊Μ歃堧硠搿� 84.7%鞐愳劀 98.1% 靷澊鞛呺媹雼�. 鞚胳垬 鞝滌晥鞚 Blazing Star Parent, LLC鞐� 鞚橅暅 WBA 鞚胳垬臧 鞕勲霅橃柎 WBA臧 鞕勳爠 鞛愴殞靷皜 霅橂姅 瓴冹潉 臁瓣贝鞙茧 頃╇媹雼�.

Blazing Star Merger Sub a prolong茅 l'heure d'expiration et la date de r猫glement de l'offre publique d'achat et de la sollicitation de consentement pr茅c茅demment annonc茅es pour les titres de Walgreens Boots Alliance (NASDAQ: WBA). La date limite est repouss茅e jusqu'脿 17h00, heure de New York, le 21 ao没t 2025, et le r猫glement est d茅sormais pr茅vu le 26 ao没t 2025.

L'offre concerne plusieurs s茅ries d'obligations senior avec des taux d'int茅r锚t et des 茅ch茅ances vari茅s, allant de 2025 脿 2050. Des portions significatives de chaque s茅rie ont d茅j脿 茅t茅 pr茅sent茅es 脿 l'offre, avec des taux de participation variant de 84,7% 脿 98,1% selon les s茅ries. L'offre est soumise 脿 la r茅alisation de l'acquisition de WBA par Blazing Star Parent, LLC, 脿 l'issue de laquelle WBA deviendra une filiale en propri茅t茅 exclusive.

Blazing Star Merger Sub hat die Frist f眉r das zuvor angek眉ndigte Angebots- und Zustimmungsgesuch f眉r Anleihen von Walgreens Boots Alliance (NASDAQ: WBA) sowie das Abwicklungsdatum verl盲ngert. Die Frist wurde bis 17:00 Uhr New Yorker Zeit am 21. August 2025 verl盲ngert, die Abwicklung ist nun f眉r den 26. August 2025 vorgesehen.

Das Angebot umfasst mehrere Serien von Senior Notes mit unterschiedlichen Zinss盲tzen und Laufzeiten von 2025 bis 2050. Wesentliche Anteile jeder Serie wurden bereits angeboten; die Beteiligungsquoten liegen je nach Serie zwischen 84,7% und 98,1%. Das Angebot steht unter der aufschiebenden Bedingung des Abschlusses der 脺bernahme von WBA durch Blazing Star Parent, LLC, durch die WBA eine hundertprozentige Tochtergesellschaft wird.

Positive
  • None.
Negative
  • Withdrawal deadline has already expired, limiting noteholder flexibility
  • Remaining outstanding notes may be subject to redemption or defeasement post-merger
  • Complex multi-series tender offer increases execution complexity

Insights

Merger financing for Walgreens acquisition progresses with high bondholder participation; tender offer extended to align with merger closing.

This announcement provides critical insight into the progress of the pending acquisition of Walgreens Boots Alliance. The extension of the tender offer expiration time from August 18 to August 21, 2025, and settlement date to August 26 signals the merger is approaching completion, with the offeror explicitly stating they want the settlement to "coincide with the closing of the Merger."

The high participation rates across all ten series of notes are particularly revealing - investors have tendered between 84-98% of outstanding principal across various maturities and currencies. For the 2046 Notes, $291.8 million of $298.6 million (97.7%) has been tendered, showing exceptionally strong bondholder support for the transaction.

The tender offer targets approximately $5.3 billion equivalent in outstanding debt across multiple currencies (USD, GBP, EUR) and maturities ranging from 2025 to 2050. This comprehensive debt refinancing strategy suggests the acquirer (Blazing Star Parent/Merger Sub) is implementing a complete capital structure overhaul rather than maintaining legacy debt.

The withdrawal deadline has already passed (August 4), meaning bondholders who tendered are now locked in. For any non-tendered notes, the acquiring company has outlined three potential approaches: redemption, defeasance (maintaining payment schedules while eliminating restrictive covenants), or simply leaving them outstanding - giving the acquirer maximum flexibility in post-merger capital structure management.

This announcement effectively confirms the merger is proceeding as planned and provides strong evidence of debt market support for the transaction structure. The high tender rates eliminate uncertainty about potential bondholder resistance that could have complicated the acquisition financing.

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Blazing Star Merger Sub, Inc. (the "Offeror" announced today the extension of the Expiration Time and the Settlement Date (as defined below) for (A) the previously announced cash tender offers (each, an "Offer" and, collectively, the "Tender Offer") for any and all of Walgreens Boots Alliance, Inc.'s (NASDAQ: WBA) ("WBA") outstanding (1) 3.600% senior notes due 2025 (the "2025 Notes"), (2) 2.125% senior notes due 2026 (the "2.125% 2026 Notes"), (3) 3.450% notes due 2026 (the "3.450% 2026 Notes"), (4) 8.125% notes due 2029 (the "2029 Notes"), (5) 3.200% notes due 2030 (the "2030 Notes"), (6) 4.500% senior notes due 2034 (the "2034 Notes"), (7) 4.800% senior notes due 2044 (the "2044 Notes"), (8) 4.650% notes due 2046 (the "2046 Notes") and (9) 4.100% notes due 2050 (the "2050 Notes"), and any and all of Walgreen Co.'s (collectively with WBA, the "Company") 4.400% notes due 2042 (the "2042 Notes" and, together with the 2025 Notes, the 2.125% 2026 Notes, 3.450% 2026 Notes, the 2029 Notes, the 2030 Notes, the 2034 Notes, the 2044 Notes, the 2046 Notes, and the 2050 Notes, the "Notes"), and (B) the previously announced solicitation of consents (the "Consent Solicitation") (i) from holders of the 2025 Notes, the 2.125% 2026 Notes, the 2034 Notes and the 2044 Notes to certain proposed amendments to the indenture, dated as of November 18, 2014, by and between WBA and Computershare Trust Company, N.A. as successor to Wells Fargo Bank, National Association, as trustee (the "Trustee") (the "2014 Indenture"); (ii) from holders of the 3.450% 2026 Notes, the 2029 Notes, the 2030 Notes, the 2046 Notes and the 2050 Notes to certain proposed amendments to the indenture, dated as of December 17, 2015, by and between WBA and the Trustee (as supplemented by the First Supplemental Indenture dated as of October 13, 2021, the "2015 Indenture"); and (iii) from holders of the 2042 Notes to certain proposed amendments to the indenture, dated as of July 17, 2008, by and between Walgreen Co. and the Trustee (the "2008 Indenture" and, together with the 2014 Indenture and the 2015 Indenture, the "Indentures") (such proposed amendments are collectively referred to as the "Proposed Amendments" and such consents being solicited are each a "Consent" and collectively, the "Consents").

The Offeror announced that the previously announced Expiration Time of 11:59 p.m., New York City time, on August 18, 2025, has been extended with respect to all holders of Notes to 5:00 p.m., New York City time, on August 21, 2025, unless extended or earlier terminated by the Offeror in its sole discretion (the "Expiration Time"), and the Settlement Date (as defined in the Offer to Purchase and Consent Solicitation Statement), has been extended to August 26, 2025, unless extended or earlier terminated. The Offeror intends to extend the Expiration Time, without extending the Withdrawal Deadline (unless required by law), to have the Settlement Date coincide with the closing of the Merger. The Withdrawal Deadline of 5:00 p.m., New York City time, on August 4, 2025 (the "Withdrawal Deadline"), is not extended and has already expired and any Notes tendered may not be withdrawn. The table below outlines the approximate principal amount of the Notes validly tendered and not validly withdrawn as of the date hereof.

Title of Notes
___________________

CUSIP/ISIN(1)
_________________

Outstanding Principal Amount
______________________

Aggregate Principal
Amount Tendered
________________________________

3.600% Notes due 2025

ISIN: XS1138359663

GBP拢300,000,000

GBP拢266,391,000

2.125% Notes due 2026

ISIN: XS1138360166

EUR鈧�750,000,000

EUR鈧�692,680,000

3.450% Notes due 2026

CUSIP: 931427AQ1

ISIN: US931427AQ19

US$1,447,286,000

US$1,136,791,000

8.125% Notes due 2029

CUSIP: 931427AW8

听滨厂滨狈:
US931427AW86

US$750,000,000

US$718,639,000

3.200% Notes due 2030

CUSIP:
听931427础厂7听

滨厂滨狈:听鲍厂931427础厂74

US$500,000,000

US$423,575,000

4.500% Notes due 2034

颁鲍厂滨笔:听931427础叠4

滨厂滨狈:听鲍厂931427础叠40

US$303,296,000

US$271,788,000

4.400% Notes due 2042
(Walgreen Co.)

CUSIP: 931422AK5

ISIN: US931422AK51

US$239,422,000

US$210,306,000

4.800% Notes due 2044

CUSIP: 931427AC2

ISIN: US931427AC23

US$659,683,000

US$623,841,000

4.650% Notes due 2046

CUSIP: 931427AR9

ISIN: US931427AR91

US$298,616,000

US$291,875,000

4.100% Notes due 2050

CUSIP: 931427AT5

ISIN: US931427AT57

US$640,372,000

US$628,226,000

_________________

(1)

The CUSIP numbers and ISIN numbers referenced in this press release are included solely for the convenience of holders.聽 None of the
Offeror, the Company, the Trustee (in any of its capacities), the Dealer Manager, the Depositary and Information Agent and their respective
聽affiliates shall be held responsible for the selection or use of the referenced CUSIP numbers and ISIN numbers, and no representation is聽
made as to the correctness of any CUSIP number or ISIN number on the Notes or as indicated in this press release or any other document.聽

The Tender Offer and Consent Solicitation are being made in connection with, and are expressly conditioned upon the substantially concurrent closing of the acquisition of WBA pursuant to the agreement and plan 鈥巓f merger, dated March 6, 2025 (as amended, supplemented, waived or otherwise modified from time to 鈥巘ime, the "Merger Agreement"), by and among WBA, Blazing Star Parent, LLC (the "Parent"), the 鈥嶰fferor and the other affiliates of the Parent named therein, which provides that the Offeror will merge with and into WBA (the "Merger"), with WBA surviving the Merger as a wholly-owned subsidiary of Parent.

The terms and conditions of the Tender Offer and Consent Solicitation are described in the Offer to Purchase and Consent Solicitation Statement relating to the Notes dated as of July 22, 2025 (as amended or supplemented from time to time, the "Offer to Purchase and Consent Solicitation Statement").

General Information

The Offeror's obligations to complete the Tender Offer and Consent Solicitation are subject to and conditioned upon the following having occurred or having been waived by us with respect to such Offer: (1) the satisfaction of the Merger Condition, and (2) the satisfaction of the General Conditions (each as described in the Offer to Purchase and Consent Solicitation Statement). Each Offer and Consent Solicitation is a separate offer and are not conditioned on any other Offer or Consent Solicitation. There can be no assurance that either of the Tender Offer or Consent Solicitation will be consummated. The Offeror may amend, extend or terminate the Tender Offer and Consent Solicitation, in its sole discretion.

Any Notes not tendered and purchased pursuant to the Tender Offer will remain outstanding. To the extent any Notes remain outstanding, the Parent may cause the Company to redeem such Notes after the closing of the Merger and the consummation of the Tender Offer in accordance with the terms of the Indentures as amended by the Proposed Amendments, as applicable. Alternatively, the Parent may cause the Company to defease such Notes, in which case holders of such Notes will continue to receive interest payment on each scheduled interest payment date and principal on the stated maturity date but will not benefit from any restrictive covenants and such Notes will not be subject to any change of control offer in connection with the Merger. Finally, the Parent may leave outstanding any outstanding Notes after the closing of the Merger and the consummation of the Tender Offer. The Parent has the right to make any and all decisions with respect to any outstanding Notes in its sole discretion, subject to compliance with the terms of the agreements governing its indebtedness.

Citigroup Global Markets Inc. has been retained as the Dealer Manager in connection with the Offers and the Consent Solicitation. In their capacity as Dealer Manager, the Dealer Manager may contact holders regarding the Offer and the Consent Solicitation and may request brokers, dealers, commercial banks, trust companies and other nominees to forward this Offer to Purchase and Consent Solicitation Statement and related materials to beneficial owners of Notes. Requests for documents may be directed to Global Bondholder Services Corporation, the Depositary and Information Agent at: +1 (855) 654 2015 or [email protected]. Questions about the Tender Offer and the Consent Solicitation may be directed to Citigroup Global Markets Inc. at (800) 558-3745.

This press release is for informational purposes only. The Tender Offer and Consent Solicitation are being made solely by the Offer to Purchase and Consent Solicitation Statement. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such offering, solicitation or 9sale would be unlawful. The Tender Offer and Consent Solicitation are not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offer or Consent Solicitation to be made by a licensed broker or dealer, the Tender Offer and Consent Solicitation will be deemed to be made on behalf of the Offeror by the Dealer Manager and Solicitation Agent, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

None of the Offeror, the Company, the Trustee (in any of its capacities), the Depositary and Information Agent, the Dealer Manager and Solicitation Agent or any of their respective affiliates makes any recommendation as to whether holders should tender or refrain from tendering their Notes, and no person or entity has been authorized by any of them to make such a recommendation. Holders must make their own decision as to whether to tender Notes and, if so, the principal amount of the Notes to tender.

Forward-Looking Statements

This press release and certain statements made from time to time by us, the Company and our and 鈥巘heir respective representatives contain or incorporate by reference certain "forward-looking statements" within 鈥巘he meaning of the federal securities laws. All statements other than statements of historical facts are forward-looking statements. In many cases, you can identify forward-looking statements by terms such 鈥巃s "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," 鈥庘�"believe," "estimate," "predict," "potential" or "continue" or other similar words. These forward-looking 鈥巗tatements are only predictions. These statements relate to future events and 鈥巌nvolve known and unknown risks, uncertainties and other important factors that may cause the 鈥巃ctual outcomes to materially differ from those expressed or implied by these forward-looking statements. New factors 鈥巆ould emerge from time to time and it is not possible for us to predict all such factors. Because forward-looking 鈥巗tatements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, 鈥巠ou should not rely on these forward-looking statements as guarantees of future events. These forward-looking 鈥巗tatements speak only as of the date made and are not guarantees of future performance of results. We expressly 鈥巇isclaim any obligation or undertaking to release any updates or revisions to any forward-looking statement 鈥巆ontained or incorporated by reference herein to reflect any change in expectations with regard thereto or any 鈥巆hange of events, conditions or circumstances on which any such statement was based, except as required by law.鈥�

SOURCE Blazing Star Merger Sub, Inc.

FAQ

What is the new expiration date for Walgreens Boots Alliance's (WBA) tender offer?

The tender offer expiration time has been extended to 5:00 p.m., New York City time, on August 21, 2025, with settlement scheduled for August 26, 2025.

How many WBA notes have been tendered so far in the tender offer?

Significant portions have been tendered across all series, including 拢266.39M of 2025 Notes, 鈧�692.68M of 2026 Notes, and varying amounts of other series with participation rates between 84.7% and 98.1%.

What happens to WBA notes that are not tendered in the offer?

Untendered notes may be redeemed, defeased, or left outstanding after the merger closes, subject to Parent's discretion and compliance with debt agreements.

What are the conditions for completing WBA's tender offer?

The tender offer is conditioned upon the closing of WBA's acquisition by Blazing Star Parent, LLC and satisfaction of general conditions described in the offer documents.

Can WBA noteholders still withdraw their tendered notes?

No, the withdrawal deadline of 5:00 p.m., New York City time, on August 4, 2025 has already expired and tendered notes can no longer be withdrawn.
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Latest News

WBA Latest SEC Filings

WBA Stock Data

10.35B
713.76M
17.44%
61.48%
2.48%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
United States
DEERFIELD